Sartorius AG Extends René Fáber's Board Appointment

Sartorius AG's Supervisory Board has extended the appointment of René Fáber as a member of the Executive Board for another five years until December 31, 2031. Joining Sartorius in 2002, Dr. Fáber, who earned his Ph.D. in polymer chemistry from the Technical University of Munich, has held various management roles. Since January 2019, he has been responsible for the Bioprocess Solutions Division.

Sartorius is a prominent international partner in the biopharmaceutical research and manufacturing sectors. The company is based in Göttingen, Germany, and operates approximately 60 locations worldwide. In 2025, Sartorius generated a revenue of around 3.5 billion euros, with over 14,000 employees.